Home
    Timetable
    Registration
    Accommodation
    Contact
Home
Welcome Note
Committees
Timetable
Preliminary Topics
List of Faculty
Scientific Program
Anterior Segment Section
Retina Section
Glaucoma Section
Neuro-Ophthalmology
Pediatrics
Surgical Marathon
Symposia
Poster Presentations
Group A
Group B
Poster Presentation Guidelines
Sponsorship & Exhibition
Sponsors
Registration
Invitation Letter
Accommodation
SwissĂ´tel The Bosphorus
CME
General Information
Before you travel...
Italian Agent
Chinese Agent
Transportation
About Istanbul
Partners
Previous Congresses
COPHy 2010
COPHy 2011
The 3rd World Congress on
Controversies in Ophthalmology (COPHy)
Anterior Segment, Retina, Glaucoma

Istanbul, Turkey, March 22 - 25, 2012
  Symposia Print

Friday, March 23, 2012

Breakfast Symposium (not for CME)
A New Way to Look at Symptomatic VMA and its Treatment
(Sponsored by Thrombogenics)
Room: Fuji 1
07:15-08:15
Moderator: A. Loewenstein, Israel
            
07:15-07:25
Case studies
A. Loewenstein, Israel
  
07:25-07:35
The role of the vitreous in retinal diseases
M. DeSmet, Switzerland 
     
07:35-07:45
Overview of enzymatic vitreolysis
W. Mieler, USA
  
07:45-07:55
New option for the treatment of vitreomacular traction
F. Bandello
, Italy
  
07:55-08:05
New option for the treatment of full-thickness macular holes
A. Tufail
, UK
  
  
08:05-08:15
Case studies and discussion
Panel
  
               
  
Symposium (not for CME)
Controversies in Ophthalmology - Management of RVO
(Sponsored by Allergan)
Room: Fuji 1 & 2
12:15-13:45
Chairpersons: G. Coscas, France; A. Loewenstein, Israel
         
12:15-12:20

 
Welcome, Introductions & Objectives
Chairpersons
    
12:20-12:40
 
 

 
RVO Disease Management Debate
Is it all about VEGF?
S. Bressler, USA
Is it all about inflammatory mediators?
J. Ambati, USA
Rebuttal
  
12:40-12:50

 
What to address first?  The underlying inflammation or the fluid?
G. Coscas
, France
  
12:50-13:00

 
How to choose a first-line treatment? Pros and Cons
A. Loewenstein
, Israel
  
13:00-13:30
Open Discussion & Debate
All Speakers
    
1330-13:35
Close and Summary
Chairpersons
          
   
   
Saturday, March 24, 2012
   
Symposium (not for CME)
Dietary Supplements for Common Eye Diseases
(Sponsored by Bausch & Lomb)
Room: Fuji 2
10:30-11:30
  
10:30-10:45
 
Dietary supplements in AMD: AREDS Formulation; Lutein, zeaxanthin, and omega-3 fatty acids
S. Bressler
, USA
10:45-10:50
Q&A from the audience, panel, chairpersons
  
10:50-11:05
 
11:05-11:10
   
Dietary supplements in diabetic retinopathy
N. Bressler
, USA
Q&A from the audience, panel, chairpersons
       
11:10-11:25
 
11:25-11:30
Potential impact of dietary supplements and mortality
J. Alio, Spain
Q&A from the audience, panel, chairpersons 
 
    
Q&A from the audience and closing remarks
         
             
     
Symposium (not for CME)
Management of Dry Eye
(Sponsored by Allergan)
Room: Fuji 1
11:30-12:45
  
11:30-11:45
 
Definition and classification of dry eye syndrome
E. Messmer
, Germany
  

11:45-12:00


 
Pathology of dry eye syndrome: Osmolarity & Liquid Deficiency
P. Aragona, Italy
   
12:00-12:15

       
Pathology of dry eye syndrome: Inflammation
Y. Akova, Turkey
   
12:15-12:30
Current trends in the treatment of dry eye syndrome
K. Boboridis, Greece
      
12:30-12:45
Case studies & Discussion
Moderator: E. Messmer, Germany
Case 1
P. Aragona, Italy
Case 2
Y. Akova, Turkey
Case 3
K. Boboridis, Greece
     
           
   
Symposium (not for CME)
Individualized therapy - the modern standard in AMD care
(Sponsored by Novartis)
Room: Fuji 2
13:45-14:45
Chairperson: F. Bandello, Italy
      
13:45-13:50
    
    
Introduction
F. Bandello, Italy
    
13:50-14:00
  
   
Fixed to flexible: The evolution of VEGF regimens in wet AMD
F. Bandello, Italy
    
14:00-14:10
  
 
How can modern monitoring techniques support individualised treatment of  wet AMD?
M. Larsen
, Denmark
  
14:10-14:20
The Great Safety Debate: What is the role of emerging data on VEGF inhibition in wet AMD?
V. Chong, UK
     
14:20-14:30
 
 
14:30-14:45
Informing therapy choices in wet AMD through emerging comparative data
P. Lanzetta
, Itlay
    
Panel Discussion
       
      
   
Symposium (not for CME)
The Management of Neovascular AMD in 2011 and Beyond
(Sponsored by Bayer)
Room: Fuji 2
15:15-16:15
Chairperson: A. Loewenstein, Israel
        
15:15-15:20
  
 
15:20-15:30
 
 
15:30-15:45
 
     
Introduction to symposium
A. Loewenstein, Israel
  
VEGF Trap feature of molecule
B. Eldem, Turkey
    
The burden of the disease (wAMD)
P. Lanzetta, Italy
      
15:45-16:05
 
 
16:05-16:15
Updated clinical trial results from VIEW studies (based on Year 1 and year 2 results)
A. Loewenstein
, Israel
   
Panel Q&A
A. Loewenstein, Israel
B. Eldem, Turkey
P. Lanzetta, Italy
      
     

Home   
Copyright © 2008 Comtecmed.com. All rights reserved.   The website was last updated on 12/03/2012 Created by    WebStudio.co.il